| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051762171 |
| P356 | DOI | 10.1186/1476-4598-7-94 |
| P932 | PMC publication ID | 2639620 |
| P698 | PubMed publication ID | 19117505 |
| P5875 | ResearchGate publication ID | 23714707 |
| P50 | author | Ragnhild A. Lothe | Q11996941 |
| Rolf Inge Skotheim | Q76361066 | ||
| Geir Hoff | Q114094518 | ||
| Morten H. Vatn | Q76356809 | ||
| P2093 | author name string | Guro E Lind | |
| Vera L Costa | |||
| Gunn I Meling | |||
| Torleiv O Rognum | |||
| Espen Thiis-Evensen | |||
| Terje Ahlquist | |||
| P2860 | cites work | HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells | Q24291505 |
| cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation | Q24299157 | ||
| A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands | Q24562877 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines | Q24792846 | ||
| Methylation changes in faecal DNA: a marker for colorectal cancer screening? | Q28257322 | ||
| Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions | Q28292507 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| The epigenetic progenitor origin of human cancer | Q29617486 | ||
| Comparing the DNA hypermethylome with gene mutations in human colorectal cancer | Q33300134 | ||
| Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer | Q33337155 | ||
| Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. | Q33775531 | ||
| Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Q33888431 | ||
| Pathology of colorectal cancer | Q34296722 | ||
| Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. | Q34318634 | ||
| Expression of MAL and MAL2, two elements of the protein machinery for raft-mediated transport, in normal and neoplastic human tissue | Q34323521 | ||
| Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay | Q34338885 | ||
| MGMT promoter methylation and field defect in sporadic colorectal cancer. | Q34452509 | ||
| Epigenetic inactivation of the HOXA gene cluster in breast cancer | Q34580018 | ||
| Genetic and epigenetic alterations in colon cancer | Q34762615 | ||
| Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers | Q34769653 | ||
| CpG island methylation in aberrant crypt foci of the colorectum | Q35748049 | ||
| Aging and DNA methylation in colorectal mucosa and cancer | Q77670111 | ||
| Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I | Q77872399 | ||
| DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors | Q80098072 | ||
| O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis | Q80286842 | ||
| Promoter methylation of the PTEN gene is a common molecular change in breast cancer | Q80403566 | ||
| Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter | Q80404744 | ||
| PTEN promoter is methylated in a proportion of invasive breast cancers | Q80594418 | ||
| Hypermethylation of the MLH1 promoter with concomitant absence of transcript and protein occurs in small patches of crypt cells in unaffected mucosa from sporadic colorectal carcinoma | Q82797873 | ||
| Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. | Q35760876 | ||
| Considerations when analyzing the methylation status of PTEN tumor suppressor gene | Q35788734 | ||
| Frequent CpG island methylation in serrated adenomas of the colorectum | Q35791305 | ||
| Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis | Q35993699 | ||
| Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. | Q36276940 | ||
| Hypermethylated MAL gene - a silent marker of early colon tumorigenesis | Q36539162 | ||
| DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer | Q36613849 | ||
| RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A | Q36730389 | ||
| Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa | Q36755132 | ||
| Colorectal cancer: a multipathway disease | Q36787380 | ||
| CpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria | Q36854134 | ||
| Molecular heterogeneity of colorectal cancer: Implications for cancer control | Q37006555 | ||
| High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array | Q38308810 | ||
| Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer | Q40073646 | ||
| Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. | Q40085449 | ||
| Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. | Q40458838 | ||
| Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma | Q40524531 | ||
| Promoter methylation and silencing of PTEN in gastric carcinoma | Q43918868 | ||
| Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients | Q44678560 | ||
| Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers | Q45073501 | ||
| Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. | Q46018478 | ||
| Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomas. | Q46022384 | ||
| Epigenetic patterns in the progression of esophageal adenocarcinoma | Q46291635 | ||
| Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. | Q46718275 | ||
| The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential | Q47351603 | ||
| PTEN methylation and expression in glioblastomas | Q48232099 | ||
| Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. | Q53346861 | ||
| Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. | Q53364696 | ||
| Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. | Q53624460 | ||
| The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. | Q54572656 | ||
| Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. | Q54590260 | ||
| Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. | Q54648210 | ||
| Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. | Q54650748 | ||
| Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. | Q54719199 | ||
| Promoter methylation precedes chromosomal alterations in colorectal cancer development. | Q54878251 | ||
| ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. | Q55025133 | ||
| DNA methylation, field effects, and colorectal cancer. | Q55041248 | ||
| Angiogenesis | Q56689455 | ||
| Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia | Q57240085 | ||
| Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas | Q59549786 | ||
| P304 | page(s) | 94 | |
| P577 | publication date | 2008-12-31 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers | |
| P478 | volume | 7 |
| Q33831794 | A comprehensive look at transcription factor gene expression changes in colorectal adenomas |
| Q41956283 | A panel of genes methylated with high frequency in colorectal cancer |
| Q34514570 | A study of genomic instability in early preneoplastic colonic lesions. |
| Q34049378 | ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis |
| Q35172269 | Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis |
| Q42794721 | Analysis of O6-methylguanine-DNA methyltransferase methylation status in sporadic colon polyps. |
| Q53105640 | Anastomotic recurrence of colon cancer: Genetic analysis challenges the widely held theories of cancerous cells' intraluminal implantation and metachronous carcinogenesis. |
| Q58617824 | Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate |
| Q33728933 | CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors. |
| Q38233031 | Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis |
| Q35567859 | Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis |
| Q33645406 | Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps |
| Q37269557 | Correlation of MLH1 and MGMT methylation levels between peripheral blood leukocytes and colorectal tissue DNA samples in colorectal cancer patients |
| Q33581249 | DNA demethylation in normal colon tissue predicts predisposition to multiple cancers |
| Q51098141 | DNA hypomethylation in plasma as a cancer biomarker: when less is more? |
| Q61865606 | DNA methylation changes in ex-adenoma carcinoma of the large intestine |
| Q35191841 | DNA methylation ratio variability may impede clinical application of cancer diagnostic markers. |
| Q53325483 | DNA methylation status of the IL8 gene promoter in aggressive periodontitis. |
| Q43052904 | Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis |
| Q35728951 | Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer |
| Q33892398 | Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? |
| Q30240778 | Epigenetic Biomarkers in Colorectal Cancer |
| Q33603731 | Epigenetic Pathways in Human Disease: The Impact of DNA Methylation on Stress-Related Pathogenesis and Current Challenges in Biomarker Development |
| Q49663292 | Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives |
| Q40392338 | Epigenetic maturation in colonic mucosa continues beyond infancy in mice |
| Q34410542 | Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma. |
| Q33942280 | Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors |
| Q35119181 | Expression of RUNX3 and β-catenin in the carcinogenesis of sporadic colorectal tubular adenoma |
| Q47142809 | Functional polymorphisms in NR3C1 are associated with gastric cancer risk in Chinese population |
| Q36359503 | Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia |
| Q48229412 | Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery |
| Q41028438 | Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer |
| Q54355550 | Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. |
| Q30956148 | Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data |
| Q38761790 | Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype |
| Q46465597 | Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer |
| Q34008651 | KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients |
| Q36414307 | LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer. |
| Q34650716 | MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features |
| Q35091263 | NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. |
| Q36296760 | Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. |
| Q34374959 | Novel methylation biomarker panel for the early detection of pancreatic cancer |
| Q37832454 | Oncogenic role of RUNX3 in head and neck cancer. |
| Q24626799 | Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival |
| Q34486212 | Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma |
| Q41611412 | Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients |
| Q38321611 | Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review |
| Q46969944 | Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors |
| Q28241736 | Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence |
| Q38436710 | Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach |
| Q39472960 | RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration |
| Q37720402 | RUNX3 is multifunctional in carcinogenesis of multiple solid tumors |
| Q34606632 | RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma |
| Q35236001 | Repeated anastomotic recurrence of colorectal tumors: genetic analysis of two cases. |
| Q38491667 | Screening for differentially methylated genes among human colorectal cancer tissues and normal mucosa by microarray chip |
| Q46530603 | Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study |
| Q38656298 | Simultaneous Methylation-Level Assessment of Hundreds of CpG Sites by Targeted Bisulfite PCR Sequencing (TBPseq) |
| Q34934917 | Targeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of TCF3 to be associated with the overall survival of colorectal cancer patients |
| Q37552326 | The Effect of Sex on the Azoxymethane/Dextran Sulfate Sodium-treated Mice Model of Colon Cancer |
| Q38050410 | The RUNX family in breast cancer: relationships with estrogen signaling |
| Q27687896 | The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways |
| Q36457427 | The significance of epigenetic alterations in lung carcinogenesis |
| Q37445275 | Toward a comprehensive and systematic methylome signature in colorectal cancers |
| Q28109367 | Whole-genome methylation analysis of benign and malignant colorectal tumours |
Search more.